Profile
Michael Molyneaux worked as the Chief Medical Officer at Macrocure Ltd.
from 2013 to 2015.
He holds an MBA from Washington University in St. Louis, a doctorate from Dalhousie University, and an undergraduate degree from the University of Prince Edward Island.
Former positions of Michael Molyneaux
| Companies | Position | End |
|---|---|---|
| MACROCURE LTD | Chief Tech/Sci/R&D Officer | 30/12/2015 |
Training of Michael Molyneaux
| Washington University in St. Louis | Masters Business Admin |
| University of Prince Edward Island | Undergraduate Degree |
| Dalhousie University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Stock Market
- Insiders
- Michael Molyneaux
